We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNR
1226
Core Natural Resources Inc
CNR
$4.45B
| $205K | 0.02% |
6,000
-10,721
| -64% | -$375K |
|
|
DEST
1227
DELISTED
Destination Maternity Corporation
DEST
| $205K | 0.02% |
94,173
-50
| -0.1% | -$135 |
|
1228
Great Southern Bancorp
GSBC
$878M
| $204K | 0.02% |
3,935
-7,766
| -66% | -$412K |
|
1229
JetBlue
JBLU
$2.29B
| $204K | 0.02% |
+12,454
| New | +$213K |
|
1230
Assurant
AIZ
$14.3B
| $203K | 0.02% |
2,134
-4,049
| -65% | -$392K |
|
1231
General Dynamics
GD
$106B
| $203K | 0.02% |
+1,200
| New | +$202K |
|
1232
Stryker
SYK
$130B
| $203K | 0.02% |
1,026
-4,076
| -80% | -$734K |
|
|
ZUO
1233
DELISTED
Zuora, Inc.
ZUO
| $203K | 0.02% |
+10,134
| New | +$219K |
|
1234
Banner Corp
BANR
$2.4B
| $202K | 0.02% |
+3,723
| New | +$212K |
|
|
CCF
1235
DELISTED
Chase Corporation
CCF
| $202K | 0.02% |
+2,180
| New | +$208K |
|
1236
PAR Technology
PAR
$735M
| $201K | 0.02% |
8,227
-1,073
| -12% | -$26.2K |
|
1237
Ultragenyx Pharmaceutical
RARE
$2.55B
| $201K | 0.02% |
+2,900
| New | +$166K |
|
1238
Alpha and Omega Semiconductor
AOSL
$1.08B
| $200K | 0.02% |
17,338
-2,211
| -11% | -$24.4K |
|
1239
Stride
LRN
$3.43B
| $200K | 0.02% |
5,874
-18,322
| -76% | -$559K |
|
|
CLDT
1240
Chatham Lodging
CLDT
$586M
| $198K | 0.02% |
+10,280
| New | +$202K |
|
|
TBHC
1241
DELISTED
The Brand House Collective
TBHC
| $198K | 0.02% |
+28,178
| New | +$277K |
|
1242
Neuronetics
STIM
$166M
| $198K | 0.02% |
13,000
+1,300
| +11% | +$21.5K |
|
|
CPLG
1243
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $198K | 0.02% |
17,743
+3,007
| +20% | +$38.8K |
|
|
ANFI
1244
DELISTED
AMIRA NATURE FOODS LTD
ANFI
| $196K | 0.02% |
115,849
| – | – |
|
1245
Rayonier Advanced Materials
RYAM
$610M
| $195K | 0.02% |
14,410
-59,160
| -80% | -$801K |
|
1246
Titan Machinery
TITN
$445M
| $194K | 0.02% |
12,464
-22,936
| -65% | -$425K |
|
1247
Lesaka Technologies
LSAK
$420M
| $193K | 0.02% |
53,826
+30,348
| +129% | +$125K |
|
1248
Marten Transport
MRTN
$1.22B
| $193K | 0.02% |
+16,254
| New | +$199K |
|
|
AUD
1249
DELISTED
Audacy, Inc.
AUD
| $192K | 0.02% |
+36,666
| New | +$243K |
|
1250
A10 Networks
ATEN
$1.93B
| $191K | 0.02% |
+26,909
| New | +$183K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.